In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 2.41 million shares changing hands with its beta currently measuring 2.18. Company’s recent per share price level of $2.55 trading at -$0.24 or -8.60% at ring of the bell on the day assigns it a market valuation of $197.63M. That closing price of SLDB’s stock is at a discount of -310.2% from its 52-week high price of $10.46 and is indicating a premium of 3.92% from its 52-week low price of $2.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.34 million shares which gives us an average trading volume of 2.85 million if we extend that period to 3-months.
For Solid Biosciences Inc (SLDB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Upright in the red during last session for losing -8.60%, in the last five days SLDB remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $2.55 price level, adding 16.39% to its value on the day. Solid Biosciences Inc’s shares saw a change of -36.25% in year-to-date performance and have moved -1.54% in past 5-day. Solid Biosciences Inc (NASDAQ:SLDB) showed a performance of -5.90% in past 30-days. Number of shares sold short was 7.09 million shares which calculate 5.21 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 86.58% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -370.59% in reaching the projected high whereas dropping to the targeted low would mean a loss of -370.59% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 41.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 28.29% while estimates for its earnings growth in next 5 years are of 18.18%.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders are in possession of 0.52% of company’s total shares while institution are holding 72.81 percent of that, with stock having share float percentage of 73.19%. Investors also watch the number of corporate investors in a company very closely, which is 72.81% institutions for Solid Biosciences Inc that are currently holding shares of the company. PERCEPTIVE ADVISORS LLC is the top institutional holder at SLDB for having 6.91 million shares of worth $39.16 million. And as of 2024-06-30, it was holding 16.8725 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 4.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.579 of outstanding shares, having a total worth of $24.55 million.
On the other hand, Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 3.51 shares of worth $8.96 million or 4.53% of the total outstanding shares. The later fund manager was in possession of 854.68 shares on Dec 31, 2024 , making its stake of worth around $2.18 million in the company or a holder of 1.10% of company’s stock.
